SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 102.05+0.3%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RCMac who wrote (1372)3/16/2000 9:06:00 PM
From: A.J. Mullen  Read Replies (2) of 3202
 
RC, I remember you pointing out a long time ago, what today's WSJ states that Incyte will be due royalties for the use of it's database, irrespective of patent issues. Sometime after you had reassured on this point, I wondered if it were possible that there was some language in the agreement that made th value of royalties dependent on patent issues.

I would guess it is unlikely and that is, anyway, a second order concern. Is such language likely, in your opinion?
AJ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News